Polymer conjugates as therapeutics: future trends, challenges and opportunities

Bibliography

• Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688-701
   PubMed Web of Science ®Google Scholar
• Duncan R, Ringsdorf H, Satchi-Fainaro R. Polymer therapeutics: Polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities. Polymer therapeutics I: polymers as drugs, conjugates and gene delivery systems. Adv Drug Deliv Rev 2006;1-8
   PubMedGoogle Scholar
• Vicent MJ, Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol 2006;24:39-47
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ. Polymer–drug conjugates: current status and future trends. In: Muro S, editor, Encyclopedia of bioscience: new frontiers in drug delivery. Frontiers in Bioscience. New York: Searingtown; 2008. P. 2744-56
   Google Scholar
• Veronese FM, Harris JME. Peptide and protein PEGylation III: advances in chemistry and clinical applications. Adv Drug Deliv 2008;60:1-88
   Web of Science ®Google Scholar
• Pasut G, Sergi M, Veronese FM. Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev 2008;60:69-78
   PubMed Web of Science ®Google Scholar
• Gaspar R. Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals. Nanomedicine 2007;2:143-7
   PubMed Web of Science ®Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347-60
   PubMed Web of Science ®Google Scholar
• Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 2008;7:21-39
   PubMed Web of Science ®Google Scholar
• Modi S, Jain JP, Domb AJ, et al. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Curr Pharm Des 2006;12:4785-96
   PubMed Web of Science ®Google Scholar
• Maeda H. Polymer conjugated macromolecular drugs for tumor-specific targeting. In: Domb AJ, editor, Polymeric site-specific pharmacotherapy. John Wiley & Sons Ltd; 1994. p. 95-116
   Google Scholar
• Seib FP, Jones AT, Duncan R. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16F10 melanoma cells. J Control Rel 2007;117:291-300
   PubMed Web of Science ®Google Scholar
• XyotaxTM, CT-2103 or PPX from cell therapeutics. Available from: http://www.ctiseattle.com
   Google Scholar
• Singer JW. Paclitaxel poliglumex (XYOTAX™, CT-2103): a macromolecular taxane. J Control Rel 2005;109:120-6
   PubMed Web of Science ®Google Scholar
• Haag R, Kratz F. Polymer therapeutics: concepts and applications. Angew Chem Int Ed 2006;45:1198-215
   PubMed Web of Science ®Google Scholar
• Pasut G, Veronese FM. Polymer–drug conjugation, recent achievements and general strategies. Prog Polym Sci 2007;32:933-61
   Web of Science ®Google Scholar
• Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp 1975;51:135-53
   Google Scholar
• Jatzkewitz H. Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone. Hoppe Seylers Z Physiol Chem 1954;297:149-56
   PubMedGoogle Scholar
• Huang PS, Oliff A. Drug-targeting strategies in cancer therapy. Curr Opin Genet Dev 2001;11:104-10
   PubMed Web of Science ®Google Scholar
• Vasey PA, Kaye SB, Morrison R, et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Campaign Phase I/II Committee. Clin Cancer Res 1999;5:83-94
   PubMed Web of Science ®Google Scholar
• Danhauser-Riedl S, Hausmann E, Schick H-D, et al. Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drug 1993;11:187-95
   PubMed Web of Science ®Google Scholar
• Seymour LW, Miyamoto Y, Maeda H, et al. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur J Cancer 1995;31A:766-70
   PubMed Web of Science ®Google Scholar
• XMT-1001 from Mersana Therapeutics. Available from: http://www.mersana.com
   Google Scholar
• XMT-1001, a novel polymeric pro-drug of camptothecin, is a potent inhibitor of LS174 and A2780 human tumor xenografts in a mouse model. Am Assoc Cancer Res 2007; Los Angeles (USA)
   Google Scholar
• Davis ME, Gonzalez H, Hwang SSJ. Linear cyclodextrin copolymers. US7091192; 2006
   Google Scholar
• Available from: http://www.insertt.com
   Google Scholar
• Schluep T, Hwang J, Cheng J, et al. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin Cancer Res 2006;12:1606-14
   PubMed Web of Science ®Google Scholar
• De Luca G, Marini RB. ONCOFID. EP2004035629; 2004
   Google Scholar
• Available from: http://www.fidiapharma.com
   Google Scholar
• Wang N, Dong AJ, Tang HD, et al. Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers. Macromol Biosci 2007;7:1187-98
   PubMed Web of Science ®Google Scholar
• Tomlinson R, Klee M, Garrett S, et al. Pendent chain functionalized polyacetals that display pH-dependent degradation: a platform for the development of novel polymer therapeutics. Macromolecules 2002;35:473-80
   Web of Science ®Google Scholar
• Vicent MJ, Tomlinson R, Brocchini S, et al. Polyacetal-diethylstilboestrol: a polymeric drug designed for pH-triggered activation. J Drug Target 2004;12:491-501
   PubMed Web of Science ®Google Scholar
• Webster R, Didier E, Harris P, et al. PEGylated proteins: Evaluation of their safety in the absence of definitive metabolism studies. Drug Metab Dispos 2007;35:9-16
   PubMed Web of Science ®Google Scholar
• Brocchini S, Godwin A, Balan S, et al. Disulfide bridge based PEGylation of proteins. Adv Drug Deliv Rev 2008;60:3-12
   PubMed Web of Science ®Google Scholar
• Fontana A, Spolaore B, Mero A, et al. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev 2008;60:13-28
   PubMed Web of Science ®Google Scholar
• Duncan R, Gilbert H, Carbajo RJ, et al. Polymer masked-unmasked protein therapy (PUMPT). 1. Bioresponsive dextrin-trypsin and -MSH conjugates designed for α-amylase activation. Biomacromolecules 2008;9:1146-54
   PubMed Web of Science ®Google Scholar
• Hoffman AS, Stayton PS. Conjugates of stimuli-responsive polymers and proteins. Prog Polym Sci 2007;32:922-32
   Web of Science ®Google Scholar
• Salmaso S, Bersani S, Pennadam SS, et al. Avidin bioconjugate with a thermoresponsive polymer for biological and pharmaceutical applications. Int J Pharm 2007;340:20-8
   PubMed Web of Science ®Google Scholar
• Richardson S, Ferruti P, Duncan R. Poly(amidoamine)s as potential endosomolytic polymers: evaluation in vitro and body distribution in normal and tumour-bearing animals. J Drug Target 1999;6:391-404
   PubMed Web of Science ®Google Scholar
• Jain R, Standley SM, Frechet JMJ. Synthesis and degradation of pH-sensitive linear poly(amidoamine)s. Macromolecules 2007;40:452-7
   Web of Science ®Google Scholar
• Lackey CA, Murthy N, Press OW, et al. Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates. Bioconjug Chem 1999;10:401-405
   PubMed Web of Science ®Google Scholar
• Hawker CJ, Wooley KL. The convergence of synthetic organic and polymer chemistries. Science 2005;309:1200-5
   PubMed Web of Science ®Google Scholar
• Ali M, Brocchini S. Synthetic approaches to uniform polymers. Adv Drug Deliv Rev 2006;58:1671-87
   PubMed Web of Science ®Google Scholar
• Hatada K. Uniform polymers. Prog Polym Sci 1999;24:1405-8
   Web of Science ®Google Scholar
• Hatada K, Kitayama T, Ute K, et al. Synthetic uniform polymers and their use for understanding fundamental problems in polymer chemistry. Macromol Rapid Commun 2004;25:1447-77
   Web of Science ®Google Scholar
• Jain NK, Asthana A. Dendritic systems in drug delivery applications. Expert Opin Drug Deliv 2007;4:495-512
   PubMed Web of Science ®Google Scholar
• Lee CC, MacKay JA, Fréchet JMJ, et al. Designing dendrimers for biological applications. Nat Biotechnol 2005;23:1517-26
   PubMed Web of Science ®Google Scholar
• Kainthan RK, Hester SR, Levin E, et al. In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007;28:4581-90
   PubMed Web of Science ®Google Scholar
• Mishra MK, Kobayashi S. Star and hyperbranched polymers. 5th edition. Plastic engineering series 53. New York: Marcel Dekker; 1999
   Google Scholar
• Schluter AD. A covalent chemistry approach to giant macromolecules with cylindrical shape and an engineerable interior and surface. Top Curr Chem 2005;245:151-91
   Web of Science ®Google Scholar
• Grayson S, Godbey W. The role of macromolecular architecture in passively targeted polymeric carriers for drug and gene delivery. J Drug Target 2008; In press
   PubMedGoogle Scholar
• Frechet JMJ. Dendrimers and other dendritic macromolecules: from building blocks to functional assemblies in nanoscience and nanotechnology. J Polym Sci Part A Polym Chem 2003;41:3713-25
   Web of Science ®Google Scholar
• Liu M, Frechet JMJ. Designing dendrimers for drug delivery. Pharm Sci Technol Today 1999;21:393-401
   Google Scholar
• Boas U, Heegaard PM. Dendrimers in drug research. Chem Soc Rev 2004;33:43-63
   PubMed Web of Science ®Google Scholar
• Vögtle F. Dendrimers II: architecture, nanostructure and supramolecular chemistry. Top Curr Chem Berlin: Springer; 2000; 210
   Google Scholar
• Frechet JM, Tomalia DA. Dendrimers and dendritic polymers. New York: John Wiley and Sons; 2001
   Google Scholar
• Tomalia DA, Baker H, Dewald J, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J 1985;17:117-32
   Web of Science ®Google Scholar
• Hawker C, Frechet JM. Preparation of polymers with controlled molecular architecture: a new convergent approach to dendritic macromolecules. J Am Chem Soc 1990;112:7638-47
   Web of Science ®Google Scholar
• Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol 2002;6:742-8
   PubMed Web of Science ®Google Scholar
• Svenson S. Dendrimers. Kirk-othmer encyclopedia of chemical technology. 5th edition. 2007. p. 786-812
   Google Scholar
• Svenson S, Tomalia DA. Commentary – dendrimers in biomedical applications – reflections on the field. Adv Drug Deliv Rev 2005;57:2106-29
   PubMed Web of Science ®Google Scholar
• Tomalia DA. Dendrimer molecules. Sci Am 1995;42-6
   Google Scholar
• Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007;35:61-7
   PubMed Web of Science ®Google Scholar
• Herborn CU, Barkhausen J, Paetsch I, et al. Coronary arteries: Contrast-enhanced MR imaging with SH L 643A – experience in 12 volunteers. Radiology 2003;229:217-23
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Bourne N, Ayisi NK, et al. Evaluation of formulated dendrimer SPL7013 as a microbicide. Antiviral Res 2003;57:A66-6
   Google Scholar
• Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 2005;57:2215-37
   PubMed Web of Science ®Google Scholar
• Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res 2006;23:1-30
   PubMed Web of Science ®Google Scholar
• Hadjichristidis N, Pitsikalis M, Pispas S, et al. Polymers with complex architecture by living anionic polymerization. Chem Rev 2001;101:3747-92
   PubMed Web of Science ®Google Scholar
• Georgiou TK, Vamvakaki M, Patrickios CS, et al. Nanoscopic cationic methacrylate star homopolymers: synthesis by group transfer polymerization, characterization and evaluation as transfection reagents. Biomacromolecules 2004;5:2221-9
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen Z, Barriau E, et al. Synthesis of multiarm star poly(glycerol)-block-poly(2-hydroxyethyl methacrylate). Biomacromolecules 2006;7:919-26
   PubMed Web of Science ®Google Scholar
• Braunecker WA, Matyjaszewski K. Controlled/living radical polymerization: Features, developments, and perspectives. Prog Polym Sci 2007;32:93-146
   Web of Science ®Google Scholar
• Mayadunne RTA, Jeffery J, Moad G, et al. Living free radical polymerization with reversible addition-fragmentation chain transfer (RAFT polymerization): approaches to star polymers. Macromolecules 2003;36:1505-13
   Web of Science ®Google Scholar
• Matyjaszewski K, Xia J. Atom transfer radical polymerization. Chem Rev 2001;101:2921-90
   PubMed Web of Science ®Google Scholar
• Kato M, Kamigaito M, Sawamoto M, et al. Polymerization of methyl-methacrylate with the carbon-tetrachloride dichlorotris(triphenylphosphine)ruthenium (II) methylaluminum bis (2,6-di-tert-butylphenoxide) initiating system – possibility of living radical polymerization. Macromolecules 1995;28:1721-3
   Web of Science ®Google Scholar
• Miura Y, Koketsu D, Kobayashi K. Synthesis and properties of a well-defined glycopolymer via living radical polymerization. Polym Adv Technol 2007;18:647-51
   Web of Science ®Google Scholar
• Otsu T, Yoshida M. Role of Initiqtor-Transfer AGent-Terminator (INIFERTER) in radical polymerizations: polymer design by organic disulfides as iniferters. Makromol Chem Rapid Commun 1982;3:127-32
   Google Scholar
• Goto A, Sato K, Tsujii Y, et al. Mechanism and kinetics of RAFT-based living radical polymerizations of styrene and methyl methacrylate. Macromolecules 2001;34:402-8
   Web of Science ®Google Scholar
• Quinn JF, Rizzardo E, Davis TP. Ambient temperature reversible addition-fragmentation chain transfer polymerisation. Chem Commun 2001;1044-5
   Web of Science ®Google Scholar
• Hwang JY, Li RC, Maynard HD. Well-defined polymers with activated ester and protected aldehyde side chains for bio-functionalization. J Control Rel 2007;122:279-86
   PubMed Web of Science ®Google Scholar
• Fischer H. The persistent radical effect: a principle for selective radical reactions and living radical polymerizations. Chem Rev 2001;101:3581-610
   PubMed Web of Science ®Google Scholar
• Quirk RP, Youngjoon L, Kim J. Star and hyperbranched polymers. In: Mishra MK, Kobayashi S, editors, Synthesis of branched polymers: an introduction. New York: Marcel Dekker; 1999. p. 1-25
   Google Scholar
• Wang D, Kopeckova JP, Minko T, et al. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. Biomacromolecules 2000;1:313-9
   PubMed Web of Science ®Google Scholar
• Nicolas J, Mantovani G, Haddleton DM. Living radical polymerization as a tool for the synthesis of polymer–protein/peptide bioconjugates. Macromol Rapid Commun 2007;28:1083-111
   Web of Science ®Google Scholar
• Geng J, Mantovani G, Tao L, et al. Site-directed conjugation of ‘Clicked’ glycopolymers to form glycoprotein mimics: Binding to mammalian lectin and induction of immunological function. J Am Chem Soc 2007;129:15156-63
   PubMed Web of Science ®Google Scholar
• Ladmiral V, Mantovani G, Clarkson GJ, et al. Synthesis of neoglycopolymers by a combination of ‘click chemistry’ and living radical polymerization. J Am Chem Soc 2006;128:4823-30
   PubMed Web of Science ®Google Scholar
• Lee CC, Yoshida M, Frechet JM, et al. In vitro and in vivo evaluation of hydrophilic dendronized linear polymers. Bioconjug Chem 2005;16:535-41
   PubMed Web of Science ®Google Scholar
• Ihre HR, Padilla De Jesus OL, Szoka FC Jr, et al. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. Bioconjug Chem 2002;13:443-52
   PubMed Web of Science ®Google Scholar
• Hawker CJ, Frechet JMJ. The synthesis and polymerization of a hyperbranched polyether macromonomer. Polymer 1992;33:1507-11
   Web of Science ®Google Scholar
• Karakaya B, Claussen W, Gessler K, et al. Toward dendrimers with cylindrical shape in solution. J Am Chem Soc 1997;119:3296-301
   Web of Science ®Google Scholar
• Parrish B, Emrick T. Soluble camptothecin derivatives prepared by click cycloaddition chemistry on functional aliphatic polyesters. Bioconjug Chem 2007;18:263-7
   PubMed Web of Science ®Google Scholar
• Yin R, Zhu Y, Tomalia DA, et al. Architectural copolymers: rod-shaped, cylindrical dendrimers. J Am Chem Soc 1998;120:2678-9
   Web of Science ®Google Scholar
• Gillies ER, Frechet JMJ. Designing macromolecules for therapeutic applications: polyester dendrimer-poly (ethylene oxide) ‘Bow-Tie’ hybrids with tunable molecular weight and architecture. J Am Chem Soc 2002;124:14137-46
   PubMed Web of Science ®Google Scholar
• Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Rel 2000;65:133-48
   PubMed Web of Science ®Google Scholar
• Berthiaume EP, Medina C, Swanson JA. Molecular size-fractionation during endocytosis in macrophages. J Cell Biol 1995;129:989-98
   PubMed Web of Science ®Google Scholar
• Xyloyiannis M, Padilla De Jesus OL, Frechet JM, et al. PEG-dendron architecture influences endocytic capture and intracellular trafficking. Proc Int Symp Control Rel Bioact Mat 2003
   Google Scholar
• Khandare JJ, Jayant S, Singh A, et al. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug Chem 2006;17:1464-72
   PubMed Web of Science ®Google Scholar
• Fischer D, Li Y, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121-31
   PubMed Web of Science ®Google Scholar
• Kovar M, Strohalm J, Etrych T, et al. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Bioconjug Chem 2002;13:206-15
   PubMed Web of Science ®Google Scholar
• Dayam R, Grande F, Al-Mawsawi LQ, et al. Recent advances in the design and discovery of small-molecule therapeutics targeting HER2/neu. Expert Opin Ther Patents 2007;17:83-102
   Web of Science ®Google Scholar
• Eskens F, Verweij J. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors. A review. Eur J Cancer 2006;42:3127-39
   PubMed Web of Science ®Google Scholar
• Fiebig HH, Burger AM. Target-directed in vitro and in vivo testing procedures for the discovery of anticancer agents. Clin Cancer Res 1999;5:S3870
   Google Scholar
• Satchi-Fainaro R, Puder M, Davies JW, et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 2004;10:255-61
   PubMed Web of Science ®Google Scholar
• Available from: http://www.syndevrx.com
   Google Scholar
• Chesler L, Goldenberg DD, Seales IT, et al. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res 2007;67:9435-42
   PubMed Web of Science ®Google Scholar
• Satchi-Fainaro R, Mamluk R, Wang L, et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005;7:251-61
   PubMed Web of Science ®Google Scholar
• Folkman J, Satchi-Fainaro R. Treating angiogenic disease, comprises administering a humanized anti-vascular endothelial growth factor monoclonal antibody and N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer TNP-470 conjugate. WO2006084054-A2; 2005
   Google Scholar
• Satchi-Fainaro R, Birsner AE, Butterfield C, et al. HPMA copolymer-TNP-470 (caplostatin) and avastin show synergistic inhibition of human tumor growth in mice. EJC Suppl 2005;3:15
   Google Scholar
• Mitra A, Nan A, Papadimitriou JC, et al. Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nucl Med Biol 2006;33:43-52
   PubMed Web of Science ®Google Scholar
• Singh RK, Gutman M, Bucana CD, et al. Interferon-alpha and interferon-beta down-regulate the expression of basic fibroblast growth-factor in human carcinomas. Proc Natl Acad Sci USA 1995;92:4562-6
   PubMed Web of Science ®Google Scholar
• Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003;2:214-21
   PubMed Web of Science ®Google Scholar
• Vicent MJ. Polymer–drug conjugates as modulators of cellular apoptosis. AAPS J 2007;9:E200-7
   PubMed Web of Science ®Google Scholar
• Oman M, Liu JH, Chen J, et al. Using N-(2-hydroxypropyl) methacrylamide copolymer drug bioconjugate as a novel approach to deliver a Bcl-2-targeting compound HA14-1 in vivo. Gene Ther Mol Biol 2006;10A:113-22
   Web of Science ®Google Scholar
• Chandna P, Saad M, Wang Y, et al. Targeted proapoptotic anticancer drug delivery system. Mol Pharm 2007;4:668-78
   PubMed Web of Science ®Google Scholar
• Guo DD, Moon HS, Arote R, et al. Enhanced anticancer effect of conjugated linoleic acid by conjugation with Pluronic F127 on MCF-7 breast cancer cells. Cancer Lett 2007;254:244-54
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Akaike T, et al. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003;63:3567-74
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Akaike T, et al. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 2004;109:1-8
   PubMed Web of Science ®Google Scholar
• Campo MA, Gabriel D, Kucera P, et al. Polymeric photosensitizer prodrugs for photodynamic therapy. Photochem Photobiol 2007;83:958-65
   PubMed Web of Science ®Google Scholar
• Kamada H, Tsutsumi Y, Yamamoto Y, et al. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice. Cancer Res 2000;60:6416-20
   PubMed Web of Science ®Google Scholar
• Murdoch D, Sager J. Will targeted therapy hold its promise? An evidence-based review. Curr Opin Oncol 2008;20:104-11
   PubMed Web of Science ®Google Scholar
• Broxterman HJ, Georgopapadakou NH. Anticancer therapeutics: “addictive” targets, multi-targeted drugs, new drug combinations. Drug Resist Updat 2005;8:183-97
   PubMed Web of Science ®Google Scholar
• Varticovski L, Lu ZR, Mitchell K, et al. Water-soluble HPMA copolymer-wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo. J Control Rel 2001;74:275-81
   PubMed Web of Science ®Google Scholar
• Sherman MR, Saifer MGP, Perez-Ruiz F. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv Drug Deliv Rev 2008;60:59-68
   PubMed Web of Science ®Google Scholar
• Available from: http://www.mvpharm.com
   Google Scholar
• Hershfield M, Kelly SJ. Recombinant mammalian uricase protein which used to treat elevated uric acid levels associated with e.g. gout is modified by the insertion of one or more lysine residues. WO200008196-A; EP1100880-A; WO200008196-A2; AU9953365-A; EP1100880-A2; BR9913360-A; CZ200100466-A3; KR2001053633-A; HU200103205-A2; CN1322243-A; ZA200100974-A; JP2002524053-W; MX2001001342-A1; NZ509633-A; AU766421-B; IN200100165-P4; US7056713-B1; US2006188971-A1
   Google Scholar
• Available from: http://www.savientpharma.com
   Google Scholar
• Barnes T, Moots R. Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol. Int J Nanomed 2007;2:3-7
   PubMed Web of Science ®Google Scholar
• Available from: http://www.ucb-group.com
   Google Scholar
• Desjarlais JR, Filikov A, Steed PM, et al. Antagonizing soluble tumor necrosis factor alpha (TNF-alpha) activity without significantly altering the activity of transmembrane TNF-alpha by administering a polyethylene glycol (PEG)ylated TNF-alpha to a patient. US2006257360-A1; 2007
   Google Scholar
• The anti-TNF certolizumab pegol in combination with methotrexate is significantly more effective than methotrexate alone in the treatment of patients with active rheumatoid arthritis: preliminary results from the RAPID 1 study. EULAR 2007 Meeting; 2007; Barcelona, Spain
   Google Scholar
• Dinesen L, Travis S. Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomed 2007;2:39-47
   PubMed Web of Science ®Google Scholar
• Available from: http://www.nektar.com
   Google Scholar
• Zappe H, Snell ME, Bossard MJ. PEGylation of cyanovirin-N, an entry inhibitor of HIV. Adv Drug Deliv Rev 2008;60:79-87
   PubMed Web of Science ®Google Scholar
• Vlieghe P, Clerc T, Pannecouque C, et al. Synthesis of new covalently bound-carrageenan-AZT conjugates with improved anti-HIV activities. J Med Chem 2002;45:1275-83
   PubMed Web of Science ®Google Scholar
• Gao Y, Katsuraya K, Kaneko Y, et al. Synthesis of azidothymidine-bound sulfated alkyl oligosaccharides and their inhibitory effects on AIDS infection in vitro. Polym J 1998;30:243-8
   Web of Science ®Google Scholar
• Cavallaro G, Maniscalco L, Caliceti P, et al. Glycosilated macromolecular conjugates of antiviral drugs with a polyaspartamide. J Drug Target 2004;12:593-605
   PubMed Web of Science ®Google Scholar
• Shaunak S, Thomas S, Gianasi E, et al. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol 2004;22:977-84
   PubMed Web of Science ®Google Scholar
• Bioresponsive dextrin-EGF conjugates designed to promote tissue regeneration in impaired human wound healing. International Symposium on Polymer Therapeutics. ISPT-07; 2007, 44; Berlin, Germany
   Google Scholar
• Pan H, Kopeckova P, Liu J, et al. Stability in plasmas of various species of HPMA Copolymer-PGE1; conjugates. Pharm Res 2007;24:2270-80
   PubMed Web of Science ®Google Scholar
• Vicent MJ, Pérez-Payá E. Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine. J Med Chem 2006;49:3763-65
   PubMed Web of Science ®Google Scholar
• Mondragón L, Orzáez M, Sanclimens G, et al. Modulation of cellular apoptosis with Apaf-1 inhibitors. pharmacological inhibition of Apaf-1 decreases cell death as antiapoptotic therapy for apoptosis-related pathologies. J Med Chem 2008;51:521-9.
   PubMed Web of Science ®Google Scholar
• Nemunaitis JJ, Leighl N, Miller W, et al. Paclitaxel poliglumex (PPX) in combination with carboplatin (carb) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): preliminary data. J Clin Oncol 2005;23:S677
   Google Scholar
• Sakai T, Lino S, Okuno T, et al. High response rates with peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive Japanese chronic hepatitis C patients: a randomised, double-blind, multicentre, phase III trial. J Hepatol 2006;44(Suppl 2):S224
   Web of Science ®Google Scholar
• Schering-Plough press release, November 2007. Available from: http://www. Schering-Plough.com
   Google Scholar
• ViroPharma. Available from: http://www.viropharma.com
   Google Scholar
• Available from: http://www.clinicaltrials.gov
   Google Scholar
• Neggers S, van Aken MO, Janssen J, et al. Long-term efficacy and safety of combined treatment of somatostatin analogs and Pegvisomant in acromegaly. J Clin Endocrinol Metab 2007;92:4598-601
   PubMed Web of Science ®Google Scholar
• Fang J, Deng D, Nakamura H, et al. Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase. Int J Cancer 2008;122:1135-44
   PubMed Web of Science ®Google Scholar
• Chugai Pharmaceutical. Available from: http://www.chugai.com
   Google Scholar
• Dipetrillo TA, Milas L, Evans D, et al. Paclitaxel poliglumex (PPX-xyotax) and concurrent radiation for esophageal and gastric cancer – a phase I study. Am J Clin Oncol Canc 2006;29:376-9
   PubMed Web of Science ®Google Scholar
• Shiah JG, Sun Y, Kopeckova P, et al. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e6;-OV-TL 16 antibody immunoconjugates. J Control Rel 2001;74:249-53
   PubMed Web of Science ®Google Scholar
• Dharap SS, Wang Y, Chandna P, et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA 2005;102:12962-7
   PubMed Web of Science ®Google Scholar
• Vicent MJ, Greco F, Nicholson RI, et al. Polymer therapeutics designed for a combination therapy of hormone-dependent cancer. Angew Chem Int Ed 2005;44:4061-6
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ, Gee S, et al. The mechanism of enhanced cytotoxicity of HPMA copolymer-DOX-AGM in breast cancer cells. J Control Rel 2007;117:28-39
   PubMed Web of Science ®Google Scholar
• Santucci L, Mencarelli A, Renga B, et al. Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. FASEB J 2006;20:765-7
   PubMed Web of Science ®Google Scholar
• Khandare JJ, Chandna P, Wang Y, et al. Novel polymeric prodrug with multivalent components for cancer therapy. J Pharmacol Exp Ther 2006;317:929-37
   PubMed Web of Science ®Google Scholar
• Available from: http://www.cytimmune.com
   Google Scholar
• Preliminary results of a phase I clinical trial of CYT-6091: a PEGylated colloidal gold-TNF nanomedicine [abstract 3603]. Am Soc Cancer Oncol 2007
   Google Scholar
• Duncan R, Gac-Breton S, Keane R, et al. Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J Control Rel 2001;74:135-46
   PubMed Web of Science ®Google Scholar
• Ferguson EL, Schmaljohann D, Duncan R. Proc. 33rd Annual Mtg. Control Rel Soc 2006;33:660
   Google Scholar
• Mendichi R, Rizzo V, Gigli M, et al. Fractionation and characterization of a conjugate between a polymeric drug-carrier and the antitumor drug camptothecin. Bioconjug Chem 2002;13:1253-8
   PubMed Web of Science ®Google Scholar
• Tarus J, Agbaria RA, Morris K, et al. Influence of the polydispersity of polymeric surfactants on the enantioselectivity of chiral compounds in micellar electrokinetic chromatography. Langmuir 2004;20:6887-95
   PubMed Web of Science ®Google Scholar
• Youan BB, Jackson TL, Dickens L, et al. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Rel 2001;76:313-26
   PubMed Web of Science ®Google Scholar
• Amidi M, Pellikaan HC, Hirschberg H, et al. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine 2007;25:6818-29
   PubMed Web of Science ®Google Scholar
• Amidi M, Pellikaan HC, De Boer AH, et al. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur J Pharm Biopharm 2008;68:191-200
   PubMed Web of Science ®Google Scholar
• Wong-Beringer A, Lambros MP, Beringer PM, et al. Suitability of caspofungin for aerosol delivery: physicochemical profiling and nebulizer choice. Chest 2005;128:3711-6
   PubMed Web of Science ®Google Scholar
• Inoue K, Baden N, Terazima M. Diffusion coefficient and the secondary structure of poly-L-glutamic acid in aqueous solution. J Phys Chem B 2005;109:22623-8
   PubMed Web of Science ®Google Scholar
• Armstrong JK, Wenby RB, Meiselman HJ, et al. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 2004;87:4259-70
   PubMed Web of Science ®Google Scholar
• Cottet H, Biron JP, Martin M. Taylor dispersion analysis of mixtures. Anal Chem 2007;79:9066-73
   PubMed Web of Science ®Google Scholar
• Kuo JH, Lin YL. Remnant cationic dendrimers block RNA migration in electrophoresis after monophasic lysis. J Biotechnol 2007;129:383-90
   PubMed Web of Science ®Google Scholar
• Cash P, Kroll JS. Protein characterization by two-dimensional gel electrophoresis. Methods Mol Med 2003;71:101-18
   PubMedGoogle Scholar
• Zhang G, Fenyo D, Neubert TA. Use of DNA ladders for reproducible protein fractionation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for quantitative proteomics. J Proteome Res 2008;7:678-86
   PubMed Web of Science ®Google Scholar
• Pan C, Xu S, Zhou H, et al. Recent developments in methods and technology for analysis of biological samples by MALDI-TOF-MS. Anal Bioanal Chem 2007;387:193-204
   PubMed Web of Science ®Google Scholar
• Klee JE. Review: mass spectrometry of step-growth polymers. Eur J Mass Spectrom (Chichester, Eng) 2005;11:591-610
   PubMed Web of Science ®Google Scholar
• Chen H, He M, Pei J, et al. Quantitative analysis of synthetic polymers using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 2003;75:6531-5
   PubMed Web of Science ®Google Scholar
• Svergun DI, Ekstrom F, Vandegriff KD, et al. Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle x-ray scattering: implications for a new oxygen therapeutic. Biophys J 2008;94:173-81
   PubMed Web of Science ®Google Scholar
• Neylon C. Small angle neutron and X-ray scattering in structural biology: recent examples from the literature. Eur Biophys J 2008
   PubMedGoogle Scholar
• Mogridge J. Using light scattering to determine the stoichiometry of protein complexes. Methods Mol Biol 2004;261:113-8
   PubMedGoogle Scholar
• Chu B, Hsiao BS. Small-angle X-ray scattering of polymers. Chem Rev 2001;101:1727-61
   PubMed Web of Science ®Google Scholar
• Paul A, Vicent MJ, Duncan R. Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates. Biomacromolecules 2007;8:1573-9
   PubMed Web of Science ®Google Scholar
• Oliva A, Llabres M, Farina JB. Applications of multi-angle laser light-scattering detection in the analysis of peptides and proteins. Curr Drug Discov Technol 2004;1:229-42
   PubMedGoogle Scholar
• Rietveld IB, Smit JAM. Colligative and viscosity properties of poly(propylene imine) dendrimers in methanol. Macromolecules 1999;32:4608-14
   Web of Science ®Google Scholar
• Li XY, He X, Ng ACH, et al. Influence of surfactants on the aggregation behavior of water-soluble dendritic phthalocyanines. Macromolecules 2000;33:2119-23
   Web of Science ®Google Scholar
• Griffiths PC, Paul A, Khayat Z, et al. Understanding the mechanism of action of poly(amidoamine)s as endosomolytic polymers: correlation of physicochemical and biological properties. Biomacromolecules 2004;5:1422-7
   PubMed Web of Science ®Google Scholar
• Khayat Z, Griffiths PC, Grillo I, et al. Characterising the size and shape of polyamidoamines in solution as a function of pH using neutron scattering and pulsed-gradient spin-echo NMR. Int J Pharm 2006;317:175-86
   PubMed Web of Science ®Google Scholar
• Picout DR, Ross-Murphy SB. Rheology of biopolymer solutions and gels. Sci World J 2003;3:105-21
   Google Scholar
• Spink CH. Differential scanning calorimetry. Methods Cell Biol 2008;84:115-41
   PubMed Web of Science ®Google Scholar
• Bonincontro A, Risuleo G. Dielectric spectroscopy as a probe for the investigation of conformational properties of proteins. Spectrochim Acta A Mol Biomol Spectrosc 2003;59:2677-84
   PubMed Web of Science ®Google Scholar
• Mourey TH, Turner SR, Rubinstein M, et al. Unique behavior of dendritic macromolecules – intrinsic viscosity of polyether dendrimers. Macromolecules 1992;25:2401-6
   Web of Science ®Google Scholar
• Farrington PJ, Hawker CJ, Frechet JMJ, et al. The melt viscosity of dendritic poly(benzyl ether) macromolecules. Macromolecules 1998;31:5043-50
   PubMed Web of Science ®Google Scholar
• Huwe K, Appelhans D, Prigann J, et al. Broadband dielectric spectroscopy on the molecular dynamics in dendritic model systems. Macromolecules 2000;33:3762-6
   Web of Science ®Google Scholar
• Sreerama N, Venyaminov SY, Woody RW. Estimation of protein secondary structure from circular dichroism spectra: inclusion of denatured proteins with native proteins in the analysis. Anal Biochem 2000;287:243-51
   PubMed Web of Science ®Google Scholar
• Johnson WC Jr. Circular dichroism and its empirical application to biopolymers. Methods Biochem Anal 1985;31:61-163
   PubMedGoogle Scholar
• Barth A. Infrared spectroscopy of proteins. Biochim Biophys Acta 2007;1767:1073-101
   PubMed Web of Science ®Google Scholar
• Furer VL, Kovalenko VI, Vandyukov AE, et al. Calculation of IR spectra of the elementoorganic dendrimers. Spectrochim Acta Part A Mol Biomol Spectrosc 2002;58:2905-12
   PubMed Web of Science ®Google Scholar
• Hentschel J, ten Cate MGJ, Borner HG. Peptide-guided organization of peptide-polymer conjugates: expanding the approach from oligo- to polymers. Macromolecules 2007;40:9224-32
   Web of Science ®Google Scholar
• Campbell-Burk S, Zhong S. Biomolecular applications of heteronuclear multidimensional NMR. Curr Opin Biotechnol 1994;5:346-54
   PubMedGoogle Scholar
• Foster MP, McElroy CA, Amero CD. Solution NMR of large molecules and assemblies. Biochemistry 2007;46:331-40
   PubMed Web of Science ®Google Scholar
• Kay LE. NMR studies of protein structure and dynamics. J Magn Reson 2005;173:193-207
   PubMed Web of Science ®Google Scholar
• Wang YS, Youngster S, Grace M, et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliv Rev 2002;54:547-70
   PubMed Web of Science ®Google Scholar
• Pinciroli V, Rizzo V, Angelucci F, et al. 1H-NMR of polymer conjugates with the anticancer drug doxorubicin. Magn Reson Chem 1997;35:2-8
   Web of Science ®Google Scholar
• Fernandez-Megia E, Correa J, Riguera R. ‘Clickable’ PEG-dendritic block copolymers. Biomacromolecules 2006;7:3104
   PubMed Web of Science ®Google Scholar
• von Harpe A, Petersen H, Li Y, et al. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Rel 2000;69:309-22
   PubMed Web of Science ®Google Scholar
• Mandracchia D, Piccionello AP, Pitarresi G, et al. Fluoropolymer based on a polyaspartamide containing 1,2,4-oxadiazole units: a potential artificial oxygen(O-2) carrier. Macromol Biosci 2007;7:836-45
   PubMed Web of Science ®Google Scholar
• Sood P, Thurmond KB, Jacob JE, et al. Synthesis and characterization of AP5346, a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent. Bioconjug Chem 2006;17:1270-9
   PubMed Web of Science ®Google Scholar
• Huo R, Wehrens R, Buydens LM. Improved DOSY NMR data processing by data enhancement and combination of multivariate curve resolution with non-linear least square fitting. J Magn Reson 2004;169:257-69
   PubMed Web of Science ®Google Scholar
• Lecomte C, Guillot B, Muzet N, et al. Ultra-high resolution X-ray structure of proteins. Cell Mol Life Sci 2004;61:774-82
   PubMed Web of Science ®Google Scholar
• Brewis M, Clarkson GJ, Goddard V, et al. Silicon phthalocyanines with axial dendritic substituents. Angew Chem Int Ed 1998;37:1092-4
   Web of Science ®Google Scholar
• Gadegaard N. Atomic force microscopy in biology: technology and techniques. Biotech Histochem 2006;81:87-97
   PubMed Web of Science ®Google Scholar
• Hentschel J, Borner HG. Peptide-directed microstructure formation of polymers in organic media. J Am Chem Soc 2006;128:14142-9
   PubMed Web of Science ®Google Scholar
• Lurie DJ, Mader K. Monitoring drug delivery processes by EPR and related techniques--principles and applications. Adv Drug Deliv Rev 2005;57:1171-190
   PubMed Web of Science ®Google Scholar
• Ottaviani MF, Montalti F, Turro NJ, et al. Characterization of starburst dendrimers by the EPR technique. Copper(II) ions binding full-generation dendrimers. J Phys Chem B 1997;101:158-66
   Web of Science ®Google Scholar
• Mäder K, Bacic G, Domb A, et al. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J Pharm Sci 2000;86:126-34
   Web of Science ®Google Scholar
• Li HH, Deng YM, He GL, et al. Proton electron double resonance imaging of the in vivo distribution and clearance of a triaryl methyl radical in mice. Magn Reson Med 2002;48:530-4
   PubMed Web of Science ®Google Scholar
• Richardson JC, Bowtell RW, Mader K, et al. Pharmaceutical applications of magnetic resonance imaging (MRI). Adv Drug Deliv Rev 2005;57:1191-209
   PubMed Web of Science ®Google Scholar
• Eaton M. Nanomedicine: industry-wise research. Nat Mat 2007;6:251-3
   PubMed Web of Science ®Google Scholar
• Available from: http://www.chem.cmu.edu/groups/maty/
   Google Scholar